$10 copy of Gilead's blockbuster Sovaldi appears in Bangladesh
A $10 version of Sovaldi, the Gilead Sciences Inc. hepatitis C treatment that sells for $1,000 a pill in the US, is now available in Bangladesh and could make its way to other parts of the world where the US company doesn’t have patents.